Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.
about
Nanotechnology-based inhalation treatments for lung cancer: state of the artEngineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancementCo-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.The improvement of the anticancer effect of a novel compound benzoic acid, 2-hydroxy-, 2-D-ribofuranosylhydrazide (BHR) loaded in solid lipid nanoparticlesOne-step self-assembled nanomicelles for improving the oral bioavailability of nimodipine.Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study.Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.Potential therapeutic strategies for non - muscle invasive bladder cancer based on association of intravesical immunotherapy with p - mapa and systemic administration of cisplatin and doxorubicin.Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake.Mixed polyethylene glycol-modified breviscapine-loaded solid lipid nanoparticles for improved brain bioavailability: preparation, characterization, and in vivo cerebral microdialysis evaluation in adult Sprague Dawley rats.Recent advances in curdlan biosynthesis, biotechnological production, and applications.Lipid nanoparticles for cancer therapy: state of the art and future prospects.Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells.Solid lipid nanoparticles surface modified with anti-Contactin-2 or anti-Neurofascin for brain-targeted delivery of medicines.Polypeptide-based Micelles for Delivery of Irinotecan: Physicochemical and In vivo Characterization.Hydrophobic ion pairing as a strategy to improve drug encapsulation into lipid nanocarriers for the cancer treatment.Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells.Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies.New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell.Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.Formulation and comparative evaluation of HPMC and water soluble chitosan-based sparfloxacin nanosuspension for ophthalmic delivery.Polyanionic carbohydrate doxorubicin-dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations.Development of transmucosal patch loaded with anesthetic and analgesic for dental procedures and in vivo evaluation.Hexamethyldisiloxane-based nanoprobes for (1) H MRI oximetry.Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.Preparation and characterization of nocodazole-loaded solid lipid nanoparticles.Chitosan-based polyelectrolyte complexes as potential nanoparticulate carriers: physicochemical and biological characterization.Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy.Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations.Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery.miR-542-3p Appended Sorafenib/All-trans Retinoic Acid (ATRA)-Loaded Lipid Nanoparticles to Enhance the Anticancer Efficacy in Gastric Cancers.QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.Advances in nano-delivery systems for doxorubicin: an updated insight.A novel [Mn2(μ-(C6H5)2CHCOO)2(bipy)4](bipy)(ClO4)2 complex loaded solid lipid nanoparticles: synthesis, characterization and in vitro cytotoxicity on MCF-7 breast cancer cells.Trehalose is not a universal solution for solid lipid nanoparticles freeze-dryingBioreducible cross-linked Pluronic micelles: pH-triggered release of doxorubicin and folate-mediated cellular uptakeTo Protect and to Preserve: Novel Preservation Strategies for Extracellular VesiclesAntiproliferative and Apoptosis Triggering Potential of Paclitaxel-Based Targeted-Lipid Nanoparticles with Enhanced Cellular Internalization by Transferrin Receptors-a Study in Leukemia Cells
P2860
Q26774177-167331E1-558D-4440-92EC-0F41EE56D197Q28073956-9ECDB1BC-665B-4489-9548-C74055376D84Q30406598-770553E6-6439-4D6A-A60D-76EEAC6799DDQ35924301-CFB54F66-1431-4DC9-8939-FEBFFF048BE8Q36442194-C5E99769-B125-4F4A-B7F2-DB474A4DBAFCQ36710235-E4B184ED-15F9-4962-BB67-7790960CC1FFQ36870135-D2ED5951-C961-44EE-9122-DE50E67A2BCEQ37031597-D0905CC3-592F-46E2-8B8E-1BDC67674810Q37344348-947F3CA4-36CC-4D8F-A5B7-5FE99E78007BQ37490613-4D044BCC-DE35-4AE4-A7B6-A1B0BFA87650Q37671850-E23B4761-48F9-4FA7-A719-480729A53AEAQ37962374-849E45B4-C17C-4419-8A7E-A61D3657DF54Q38040884-5E59B290-EA83-49E2-950B-F337B2B035EDQ38717148-6F44A00C-C627-42FE-9C39-A9D5C4A485F7Q38749019-A4B0964C-D7D4-42A9-936B-6A1A485CE9A0Q38932548-A7D87F2C-CBDC-4E68-BB32-7E4BBEECFE17Q39021928-8FC56AC1-61B9-4BE6-8E28-F8E810C7A4EFQ39024424-512C5F03-DA80-4B13-8C8A-A451210DE6C5Q39130500-4CD2BBF2-0D5C-4980-8BE5-0B35F59A8882Q39176565-2F7465ED-9305-46F7-B211-7F7CD66E4071Q40331959-2C2462DB-583C-42FA-A77D-45F90FC56ACEQ40919415-8F4C9EC2-033E-43F8-A56F-C6212200C5FAQ42033682-F0EB61CA-CE5D-471D-9F8F-C81BAF26224FQ42538983-3BBEA391-9A98-417F-8120-26C72AE346B1Q42813138-CC75DA4D-F8C3-47B7-B9CA-3C5515A22C77Q43811991-6A6E32BB-D0BD-4548-8495-87CDD5212DE7Q46112177-5E1C4054-E1D7-41F7-B222-C8297BC9A963Q46885887-F3872360-E1EF-4BAC-8677-F4E1C51340FDQ48580295-B4E28050-3939-4E09-B367-2F1CB7864F64Q48626221-F80FED3B-7635-4A39-A903-D4B3A22793BDQ49058125-BAF444A8-2051-48ED-9778-6F8620CFA754Q49580450-78E1309C-2316-40E3-A46D-CD9A143B1EE0Q50094521-ABC49904-9762-4083-A829-BFF1A6F8ABA9Q50106753-0BB251CB-2B45-4537-8BF6-6C19C80BDB9EQ52851611-353DB592-E7CF-4DEE-B02A-4A652E377CE6Q57094988-0E693B79-7E16-4D32-BF79-A57AA201389DQ57371937-C3C243D9-47FE-4363-971D-712A2FC8B85FQ58699153-88B0FDB0-965C-45D2-8DBF-C74DFC44F68BQ58762058-783DCA37-9058-48E1-A2BE-FA8B4AA0406D
P2860
Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.
@en
Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.
@nl
type
label
Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.
@en
Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.
@nl
prefLabel
Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.
@en
Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.
@nl
P2093
P1476
Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.
@en
P2093
Hoo-Kyun Choi
Keon Wook Kang
Robhash Kusam Subedi
P304
P356
10.1016/J.EJPS.2009.04.008
P407
P577
2009-05-03T00:00:00Z